...
首页> 外文期刊>Journal of Biomolecular Structure and Dynamics >An insight to the dynamics of conserved water-mediated salt bridge interaction and interdomain recognition in hIMPDH isoforms
【24h】

An insight to the dynamics of conserved water-mediated salt bridge interaction and interdomain recognition in hIMPDH isoforms

机译:对hIMPDH亚型中保守的水介导的盐桥相互作用和域间识别动力学的见解

获取原文
获取原文并翻译 | 示例

摘要

Inosine monophosphate dehydrogenase (IMPDH) is involved in de novo biosynthesis pathway of guanosine nucleotide. Type II isoform of this enzyme is selectively upregulated in lymphocytes and chronic myelogenous leukemia (CML) cells, and is an excellent target for antileukemic agent. The molecular dynamics simulation results (15 ns) of three unliganded 1B3O, 1JCN, and 1JR1 structures have clearly revealed that IN, IC (N- and C-terminal of catalytic domains) and C1, C2 (cystathionine- beta-synthase-1 and 2) domains of IMPDH enzyme have been stabilized by six conserved water (center) mediated salt bridge interactions. These conserved water molecules could be involved in interdomain or intradomain recognition, intradomain coupling, and charge transfer processes. The binding propensity of cystathionine-beta-synthase domain to catalytic domain (through conserved water-mediated salt bridges) has provided a new insight to the biochemistry of IMPDH. Stereospecific interaction of IN with C2 domain through conserved water molecule (K109-WII 1-D215/D216) is observed to be unique in the simulated structure of hIMPDH-II. The geometrical/structural consequences and topological feature around the W II 1 water center may be utilized for isoform specific inhibitor design for CML cancer.
机译:肌苷单磷酸脱氢酶(IMPDH)参与鸟苷核苷酸的从头生物合成途径。该酶的II型同工型在淋巴细胞和慢性粒细胞性白血病(CML)细胞中选择性上调,是抗白血病药物的理想靶标。三种未配位的1B3O,1JCN和1JR1结构的分子动力学模拟结果(15 ns)清楚地表明,IN,IC(催化域的N和C端)和C1,C2(胱硫醚-β-合酶-1和2)IMPDH酶的结构域已经被六个保守的水(中心)介导的盐桥相互作用所稳定。这些保守的水分子可能参与域间或域内识别,域内耦合和电荷转移过程。半胱氨酸-β-合酶结构域对催化结构域的结合倾向(通过保守的水介导的盐桥)为IMPDH的生物化学提供了新的见识。在hIMPDH-II的模拟结构中,观察到IN通过保守水分子(C109-WII 1-D215 / D216)与C2域的立体特异性相互作用是独特的。 W II 1水中心附近的几何/结构后果和拓扑特征可用于CML癌症的异构体特异性抑制剂设计。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号